ABBOTT LABORATORIES (ABL.DE) Forecast, Price Target & Analyst Ratings

FRA:ABLUS0028241000

Current stock price

85.74 EUR
-1.8 (-2.06%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ABBOTT LABORATORIES (ABL.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€115.79
+ 35.05% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 14, 2026
Period
Q1 / 2026
EPS Estimate
$1.16
Revenue Estimate
11.101B

ChartMill Buy Consensus

Rating
80.57%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€115.79
Upside
+ 35.05%
From current price of €85.74 to mean target of €115.79, Based on 35 analyst forecasts
Low
€97.52
Median
€117.54
High
€141.75

Price Target Revisions

1 Month
1.34%
3 Months
-7.03%

Price Target Summary

35 Wall Street analysts provided a forecast for the next 12 months for ABL.DE. The average price target is 115.79 EUR. This implies a price increase of 35.05% is expected in the next year compared to the current price of 85.74.
The average price target has been revised downward by 7.03% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

ABL Current Analyst RatingABL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

ABL Historical Analyst RatingsABL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
80.57%
ABL.DE was analyzed by 35 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about ABL.DE.
In the previous month the buy percentage consensus was at a similar level.
ABL.DE was analyzed by 35 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-07-23Raymond JamesMaintains Outperform
2021-07-23Credit SuisseMaintains Outperform
2021-07-23Morgan StanleyMaintains Overweight
2021-07-20SVB LeerinkMaintains Market Perform
2021-07-12Wells FargoMaintains Overweight
2021-06-02BTIGMaintains Buy
2021-06-02BarclaysMaintains Overweight
2021-06-02Wells FargoMaintains Overweight
2021-06-02Raymond JamesMaintains Outperform
2021-06-02Credit SuisseMaintains Outperform
2021-06-02Morgan StanleyMaintains Overweight
2021-06-02CitigroupMaintains Buy
2021-05-25BarclaysInitiate Overweight
2021-04-21Morgan StanleyMaintains Overweight
2021-04-15Atlantic EquitiesInitiate Neutral
2021-03-11Raymond JamesMaintains Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 14, 2026
Period
Q1 / 2026
EPS Estimate
$1.16
Revenue Estimate
11.101B
Revenue Q2Q
7.17%
EPS Q2Q
6.26%
Number of Analysts
25

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-1.98%
EPS (1 Month)
-0.17%
EPS (3 Months)
-4.49%

Next Earnings Summary

ABL.DE is expected to report earnings on 4/14/2026. The consensus EPS estimate for the next earnings is 1.16 EUR and the consensus revenue estimate is 11.10B EUR.
The next earnings revenue estimate has been revised downward by 1.98% in the past 3 months.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ABL.DE revenue by date.ABL.DE revenue by date.
40.109B
-8.12%
41.95B
4.59%
44.328B
5.67%
48.804B
10.10%
52.633B
7.85%
56.232B
6.84%
59.182B
5.25%
63.47B
7.25%
67.627B
6.55%
72.345B
6.98%
77.491B
7.11%
EBITDA
YoY % growth
ABL.DE ebitda by date.ABL.DE ebitda by date.
9.965B
-16.78%
10.211B
2.47%
11.443B
12.07%
13.184B
15.21%
14.453B
9.63%
15.61B
8.01%
16.232B
3.98%
19.36B
19.27%
N/AN/AN/A
EBIT
YoY % growth
ABL.DE ebit by date.ABL.DE ebit by date.
6.722B
-22.80%
6.993B
4.03%
8.327B
19.08%
11.467B
37.71%
12.503B
9.03%
13.63B
9.01%
15.554B
14.12%
17.187B
10.50%
N/AN/AN/A
Operating Margin
ABL.DE operating margin by date.ABL.DE operating margin by date.
16.76%16.67%18.78%23.50%23.76%24.24%26.28%27.08%N/AN/AN/A
EPS
YoY % growth
ABL.DE eps by date.ABL.DE eps by date.
4.44
-16.85%
4.67
5.18%
5.15
10.28%
5.70
10.72%
6.28
10.19%
6.92
10.07%
7.43
7.37%
8.44
13.67%
9.19
8.89%
10.08
9.67%
11.06
9.72%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
1.16
6.26%
1.39
10.13%
1.47
13.09%
1.68
12.08%
1.38
18.97%
1.55
11.37%
1.62
10.22%
1.73
3.08%
1.57
13.61%
1.74
12.42%
1.79
10.33%
1.87
7.83%
Revenue
Q2Q % growth
11.101B
7.17%
12.168B
9.21%
12.548B
10.37%
12.969B
13.18%
11.965B
7.78%
12.892B
5.95%
13.278B
5.82%
13.694B
5.59%
12.825B
7.19%
13.942B
8.14%
14.397B
8.43%
14.845B
8.41%
EBITDA
Q2Q % growth
2.679B
7.89%
3.214B
-12.07%
3.405B
-24.37%
3.807B
-30.07%
3.219B
20.16%
3.536B
10.02%
3.709B
8.93%
3.904B
2.55%
3.628B
12.71%
3.949B
11.68%
4.126B
11.24%
4.247B
8.79%
EBIT
Q2Q % growth
2.279B
31.96%
2.799B
31.90%
2.971B
36.41%
3.397B
45.92%
2.701B
18.52%
3.037B
8.50%
3.222B
8.45%
3.463B
1.94%
3.206B
18.70%
3.513B
15.67%
3.671B
13.94%
3.8B
9.73%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
10.33%
EPS Next 5 Year
10.38%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
7.61%
Revenue Next 5 Year
7.06%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
14.40%
EBIT Next 5 Year
13.17%

ABBOTT LABORATORIES / ABL.DE Forecast FAQ

What is the price target for ABL stock?

35 analysts have analysed ABL.DE and the average price target is 115.79 EUR. This implies a price increase of 35.05% is expected in the next year compared to the current price of 85.74.

Can you provide the upcoming earnings date for ABBOTT LABORATORIES?

ABBOTT LABORATORIES (ABL.DE) will report earnings on 2026-04-14, before the market open.

What are the consensus estimates for ABBOTT LABORATORIES (ABL.DE) next earnings?

The consensus EPS estimate for the next earnings of ABBOTT LABORATORIES (ABL.DE) is 1.16 EUR and the consensus revenue estimate is 11.10B EUR.

Can you provide the consensus rating for ABBOTT LABORATORIES stock?

The consensus rating for ABBOTT LABORATORIES (ABL.DE) is 80.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.